- Home
- JHX vs RGC Comparison
JHX vs RGC Comparison
Compare JHX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JHX | RGC |
|---|---|---|
| Founded | 1888 | 2014 |
| Country | Ireland | Hong Kong |
| Employees | 5860 | N/A |
| Industry | Building Materials | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | JHX | RGC |
|---|---|---|
| Price | $21.98 | $27.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.83 | N/A |
| AVG Volume (30 Days) | ★ 6.8M | 160.6K |
| Earning Date | 05-19-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.06 | N/A |
| Revenue Next Year | $14.50 | N/A |
| P/E Ratio | $122.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.46 | $9.39 |
| 52 Week High | $29.83 | $950.00 |
Technical Indicators
Market Signals| Indicator | JHX | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 59.82 | 49.89 |
| Support Level | $20.71 | $22.43 |
| Resistance Level | $22.73 | $28.31 |
| Average True Range (ATR) | 0.85 | 3.58 |
| MACD | 0.39 | -0.03 |
| Stochastic Oscillator | 93.30 | 27.98 |
Price Performance
Historical ComparisonAbout JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.